Histological evidence of natural killer cell aggregation against malignant melanoma induced by adoptive immunotherapy with lymphokine-activated killer cells
- 1 March 1989
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 157 (3) , 201-204
- https://doi.org/10.1002/path.1711570305
Abstract
Adoptive immunotherapy with lymphokine‐activated killer (LAK) cells and systemic administration of recombinant Interleukin‐2 (RIL‐2) was carried out in a case of malignant melanoma with lung metastases. Histological specimens from the lung showed a metastatic melanoma heavily invaded by atypical lymphoid cells with convoluted nuclei of varying size. Immunohistochemistry revealed that these cells had the characteristic exclusively of natural killer cell (Leu‐7+). Nodules of these cells mimicked the appearance of non‐Hodgkin's lymphoma of pleomorphic type. Molecular cytogenetic analysis, however, showed the absence of rearranged bands for the T‐cell receptor beta‐chain gene, indicating the absence of T‐cell clones. At autopsy, 1 month after the LAK therapy, the heavy invasion of convoluted cells had disappeared. These findings clearly indicate that the LAK cell plus RIL‐2 therapy induced Leu‐7+ lymphoid cells, phenotypically suggestive of natural killer cell aggregation in the tumours.Keywords
This publication has 12 references indexed in Scilit:
- Rearrangement of immunoglobulin heavy chain genes and t3 expression in the absence of rearrangement of t-cell receptor β-chain gene in a patient with t-cell malignant lymphomaLeukemia Research, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.The Journal of Experimental Medicine, 1985
- Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancerCancer, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations.The Journal of Immunology, 1984
- Functional V region formation during in vitro culture of a murine immature B precursor cell lineNature, 1983
- Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.The Journal of Experimental Medicine, 1983
- Protection against syngeneic lymphoma by a long-lived cytotoxic T-cell clone.Proceedings of the National Academy of Sciences, 1982
- In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.The Journal of Immunology, 1980